HopeStage
Back to all studies
Enrolling By InvitationNCT06558201

Open Label Extension Study of NCT06221852

This study assesses depression symptoms.

Interventional studyAges 18–45United StatesSchizophrenia
The study in practice

Understand this study

What is this study about?

This study assesses depression symptoms.

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Listed locations
BelmontSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 28, 2024
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
50
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
Other
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT06558201
Official title
Show the full official title

Open Label Extension Study of NCT06221852 of the Ketogenic Diet in Participants With First Episode Bipolar Disorder.

Recruitment & locations

By invitation

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study assesses depression symptoms.

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies